To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
25 Current news about the topic anti-inflammatory drugsrss
Welichem Biotech Inc. announced that Health Canada approved the Company's Clinical Trial Application (CTA) to begin a Phase IIa Clinical Trial of its anti-inflammatory drug candidate, WBI-1001, on atopic dermatitis (a type of eczema). The Company will initiate its Phase IIa Clinical Trial of ...
Chi-Med, the Hutchison Whampoa backed pharmaceutical and healthcare Group, announced that it's wholly-owned drug R&D subsidiary, Hutchison MediPharma Limited, has obtained clearance for its new Investigative New Drug ("IND") application from the US Food and Drug Administration for its drug ...
BioXell SpA announced the initiation of a Phase IIa trial to investigate the efficacy of its lead compound BXL628, a non-hypercalcemic Vitamin D Receptor (VDR) agonist, in chronic non-bacterial prostatitis (CP/CPPS). Coordinated by the Division of Urology at the University "La Sapienza" in ...
Genzyme Corp. announced that it has completed the transaction to buy back the sales and marketing rights to Synvisc® (hylan G-F 20) in the United States and five European countries from Wyeth. The cash transaction is accretive to Genzyme. Genzyme will now record all Synvisc end-user revenue ...
Therapy of inflammatory diseases, autoimmune diseases or tissue rejection
A-Virals first human study in Europe is approved by the Ethics Committee at The Academical Medical Centre, Amsterdam. The study will be carried out under the supervision of Professor Dr. Med. Tom van der Poll at AMC, which is one of Amsterdam's larger hospitals, and also one of the city's ...